Multistate Outbreak of Listeria monocytogenes Infections Linked to start highlightQueso Frescoend highlight — United States, 2021
Weekly / May 27, 2022 / 71(21);709–712
Please note:. This report has been corrected. An erratum has been published.
Alexandra Palacios, MPH1,2; Mark Otto, MSPH3; Eileen Flaherty4; Michelle M. Boyle, MPH5; Lenka Malec, MPH6; Kelsey Holloman, MPH7; Mabel Low, MPH1,2; Allison Wellman, MPH3; Corinne Newhart, MPH3; Lauren Gollarza, MHS1; Tracey Weeks, MS4; Anthony Muyombwe, PhD4; Kristen Lozinak, MS5; Erin Kafka, MA5; Daniel O’Halloran, MPH6; Teresa Rozza6; David Nicholas, MPH9,10; Stranjae Ivory, MPH3; Katherine Kreil, MPH3; Jasmine Huffman1,8; Laura Gieraltowski, PhD1; Amanda Conrad, MPH1 (View author affiliations)View suggested citation
What is already known about this topic?
Listeriosis outbreaks are frequently associated with consumption of start highlightqueso fresco and other similar fresh, soft cheeses.end highlight
What is added by this report?
In early 2021, a multistate outbreak of listeriosis involving 13 cases in four states occurred, resulting in 12 hospitalizations and one death. The outbreak was linked to start highlightqueso frescoend highlight within 19 days of cluster detection. Rapid food testing by regulatory agencies in response to the investigation identified the implicated cheese.
What are the implications for public health practice?
To prevent severe health outcomes among persons at increased risk for listeriosis, public health agencies should improve communications, including implementing new methods of dissemination to emphasize the risk from eating start highlightqueso fresco and other similar fresh, soft cheeses,end highlight even those made with pasteurized milk.
Views equals page views plus PDF downloads
Listeriosis is a serious infection usually caused by eating food contaminated with the bacterium Listeria monocytogenes. An estimated 1,600 persons become ill with listeriosis each year, among whom approximately 260 die. Persons at higher risk for listeriosis include pregnant persons and their newborns, adults aged ≥65 years, and persons with weakened immune systems. Persons with invasive listeriosis usually report symptoms starting 1–4 weeks after eating food contaminated with L. monocytogenes; however, some persons who become infected have reported symptoms starting as late as 70 days after exposure or as early as the same day of exposure (1). On January 29, 2021, PulseNet, the national molecular subtyping surveillance network coordinated by CDC, identified a multistate cluster of three L. monocytogenes infections: two from Maryland and one from Connecticut (2). CDC, the Food and Drug Administration (FDA), and state and local partners began an investigation on February 1, 2021. A total of 13 outbreak-related cases were eventually identified from four states. All patients reported Hispanic ethnicity; 12 patients were hospitalized, and one died. Rapid food testing and record collection by regulatory agencies enabled investigators to identify a brand of queso fresco made with pasteurized milk as the likely source of the outbreak, leading to an initial product recall on February 19, 2021. start highlightQueso fresco and other similar fresh, soft cheesesend highlight made with pasteurized milk are a well-documented source of listeriosis outbreaks. These cheeses can be contaminated with L. monocytogenes unless stringent hygienic controls are implemented, and the processing environment is monitored for contamination (3). U.S. public health agencies should establish or improve communications, including new methods of disseminating information that also effectively reach Hispanic populations, to emphasize the risk from eating start highlightqueso fresco and other similar fresh, soft cheeses,end highlight even those made with pasteurized milk.
Investigation and Results
On February 1, 2021, CDC notified state and federal partners of three listeriosis illnesses from Maryland (two cases) and Connecticut (one case) uploaded to PulseNet within the previous 120 days that were highly related (i.e., within four alleles by whole genome sequencing [WGS]). Specimen collection dates ranged from October 20, 2020, to January 6, 2021. All three patients were hospitalized; no deaths were reported. Patients were aged 45–69 years, and one patient was female. All three patients reported Hispanic ethnicity. State partners interviewed patients or their surrogates using the Listeria Initiative questionnaire for hypothesis generation (4). All three patients reported consuming fresh, start highlightsoft cheesesend highlight before becoming ill; two reported consuming queso fresco, a type of fresh, start highlightsoft cheese.end highlight In this outbreak, a case was defined as an infection in a person with a clinical isolate related within five allele differences by WGS and a specimen collection date from October 20, 2020, to March 17, 2021 (Figure).
Based on food histories from the three index patients, their reported Hispanic ethnicity, and the known association between L. monocytogenes and fresh, start highlightsoft cheeses,end highlight CDC asked the Connecticut Department of Public Health (CDPH) to contact the Connecticut patient for brand information. During re-interview, the patient reported consuming brand A queso fresco. CDC conducted a case-case analysis comparing food exposures for four listeriosis patients included in the outbreak (outbreak cases) with completed Listeria Initiative questionnaires to exposures for listeriosis patients not associated with an outbreak by WGS from the same states as outbreak cases (control cases). An exact odds ratio analysis was conducted using SAS software (version 9.4; SAS Institute). Consumption of start highlightqueso fresco (odds ratio [OR] = 51.2; p = 0.002) and other similar fresh, soft cheeses (OR = 30.4; p<0.001) end highlig were both statistically significant. This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.*
A total of 13 L. monocytogenes infections that met the case definition were reported from four states (Connecticut [one], Maryland [five], New York [four], and Virginia [three]). Patients ranged in age from <1 year to 75 years (median = 51 years). All patients reported Hispanic ethnicity; seven were female. Twelve patients were hospitalized; one died. Four patients became ill during pregnancy, resulting in two pregnancy losses and one premature birth; one patient remained pregnant after becoming ill. Among the eleven patients who completed the Listeria Initiative questionnaire, start highlightseven reported consuming queso fresco; eight reported consuming other similar fresh, soft cheeses.end highlight Four patients reported consuming brands of cheeses manufactured by firm A, the firm that produces brand A queso fresco.
The Connecticut Food Protection Program and Maryland Rapid Response Team collected samples of fresh, start highlightsoft cheesesend highlight at stores reported by patients, including brand A queso fresco. Connecticut and Maryland collected and tested 61 fresh, start highlightsoft cheeseend highlight samples; two yielded L. monocytogenes. CDPH identified the outbreak strain of L. monocytogenes in two samples of brand A queso fresco. WGS analysis of isolates from the CDPH samples showed they were closely related to the clinical isolates (0–4 allele differences), suggesting that patients became ill from brand A queso fresco. All 13 clinical isolates and two cheese isolates were related within five allele differences by WGS.
Public Health Response
FDA determined that brand A queso fresco was produced by firm A, located in New Jersey, and initiated an inspection. Firm A produced or handled start highlightqueso fresco and two similar fresh, soft cheeses (requesón and quesillo)end highlight under its own brand name and for private label brands. Firm A agreed to recall brand A queso fresco products with expiration dates from February 26 to March 13, 2021. The initial recall and outbreak investigation were announced on February 19, 2021. Because of cross-contamination concerns, firm A agreed on February 26 to expand the recall to all types of start highlightcheeseend highlight produced or handled in the start highlightfacility.end highlight As a result of this investigation, firm A ceased production, repackaging, and distribution of all products manufactured at the facility.
CDC published seven outbreak notices; FDA posted nine outbreak advisories, two recall notices, and two lists of retail establishments that received recalled product. CDC and FDA communications were available in both English and Spanish. In addition, Connecticut published four public communications. Two patients who became ill after the expanded recall, both with specimen collection dates of March 17, 2021, likely purchased and consumed the queso fresco before the recall given their illness dates and the long incubation period for listeriosis (5).
Patients in this outbreak were more likely to consume start highlightqueso fresco and other similar fresh, soft cheesesend highlight compared with patients with sporadic Listeria infections reported from the same states. In listeriosis outbreaks, prompt, epidemiologically directed food sampling plays a key role in identifying the source of illness. Without the rapid identification of L. monocytogenes in firm A’s queso fresco, firm A would not have been identified as the outbreak source as quickly. The public health actions taken within 19 days of cluster identification, firm A’s voluntary recalls, and outbreak notices likely prevented additional illnesses or deaths.
In early 2020, during an unrelated outbreak of listeriosis, Listeria grayi and Listeria innocua, typically nonpathogenic to humans, were found in firm A’s processing areas. The presence of Listeria species in a processing environment indicates that L. monocytogenes could survive in that same environment. FDA issued a warning letter to firm A in 2020 because of violations of Current Good Manufacturing Practice regulations and a lack of hazard analysis and preventive control programs (6).
start highlightQueso fresco and other similar fresh, soft cheesesend highlight made with pasteurized milk continue to constitute a serious risk for listeriosis because cheeses can become contaminated during the production process (after milk pasteurization). High moisture, low salt content, and low acidity support growth of L. monocytogenes in these cheeses during refrigerated storage, thereby increasing the risk for illness (7). A study of U.S. listeriosis outbreaks associated with soft cheeses during 1998–2014 found that soft cheeses made with pasteurized milk are implicated in more outbreaks than soft cheeses made with unpasteurized milk, which might be related to higher consumption of cheese made with pasteurized milk or to public health messages advising persons at higher risk for listeriosis not to eat cheeses made with unpasteurized milk. Among 17 outbreaks linked to soft cheeses during 1998– 2014, eleven were linked to start highlightqueso fresco and other similar fresh, soft cheeses,end highlight three of which included cheeses made with unpasteurized milk. The six outbreaks not linked to start highlightthese cheesesend highlight included sheep’s milk, Middle Eastern-style, Eastern European-style, Italian-style, blue-veined, and soft-ripened cheeses (8).
start highlightQueso fresco and other similar fresh, soft cheeses,end highlight especially those produced in facilities with unhygienic processing conditions, have frequently led to listeriosis outbreaks during the last two decades (8). Rapid food testing by regulatory agencies in response to this outbreak investigation identified the implicated cheese. Public health agencies should establish or improve communications, including new methods for disseminating information to emphasize the risk from eating start highlightqueso fresco and other similar fresh, soft cheeses,end highlight even those made with pasteurized milk, to persons at higher risk for listeriosis, including pregnant persons and their newborns, adults aged ≥65 years, and persons with weakened immune systems.
Christine Applewhite, Kimberly Holmes-Talbot, Lauren Mank, Quyen Phan, Christina Turner, Connecticut Department of Public Health; Laura Kasper, Tamara Rissman, Connecticut Emerging Infections Program; Kyle Shannon, Maryland Department of Health; Lauren Turner, Virginia Division of Consolidated Laboratory Services; Christy Brennan, Virginia Department of Agriculture and Consumer Services; Jaime Ahn, Jennifer Corrieri, Helena Kim, Loel Muetter, Alan Talarsky, New Jersey Department of Health; Karen Anthony, Cornelius Brown, III, Andrew Ciaccia, Joanne DeClement, Cary Green, Martin Guardia, Kyle Hobson, Laishan Lam, Ruark Lanham, Melissa Libby, Jessica Monteiro, Valeria Moore, William Muszynski, Dhaval Patel, Robin Rivers, Brian Young, Food and Drug Administration Office of Regulatory Affairs.
Corresponding author: Alexandra Palacios, email@example.com, 470-426-4170.
1Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 2Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee; 3Food and Drug Administration, Silver Spring, Maryland; 4Connecticut Department of Public Health; 5Maryland Department of Health; 6New York City Department of Health and Mental Hygiene, New York; 7Virginia Department of Health; 8Weems Design Studio, Suwanee, Georgia; 9New York State Department of Health; 10Department of Epidemiology & Biostatistics, School of Public Health, University at Albany, Rensselaer, New York.
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
* 45 C.F.R. part 46.102(l)(2), 21 C.F.R. part 56; 42 U.S.C. Sect. 241(d); 5 U.S.C. Sect. 552a; 44 U.S.C. Sect. 3501 et seq.
- CDC. Listeria (listeriosis) questions and answers. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. https://www.cdc.gov/listeria/faq.html
- CDC. PulseNet: whole genome sequencing (WGS). Atlanta, GA: US Department of Health and Human Services, CDC; 2016. https://www.cdc.gov/pulsenet/pathogens/wgs.html
- Food and Drug Administration. Draft guidance for industry: control of Listeria monocytogenes in ready-to-eat foods. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2017. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/draft-guidance-industry-control-listeria-monocytogenes-ready-eat-foods
- CDC. Listeria (listeriosis) prevention. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https://www.cdc.gov/listeria/prevention.html
- Angelo KM, Jackson KA, Wong KK, Hoekstra RM, Jackson BR. Assessment of the incubation period for invasive listeriosis. Clin Infect Dis 2016;63:1487–9. https://doi.org/10.1093/cid/ciw569 PMID:27535950
- Food and Drug Administration. FSMA final rule for preventive controls for human food. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2020. https://www.fda.gov/food/food-safety-modernization-act-fsma/fsma-final-rule-preventive-controls-human-food
- Ibarra-Sánchez LA, Van Tassell ML, Miller MJ. Invited review: Hispanic-style cheeses and their association with Listeria monocytogenes. J Dairy Sci 2017;100:2421–32. https://doi.org/10.3168/jds.2016-12116 PMID:28189316
- Jackson KA, Gould LH, Hunter JC, Kucerova Z, Jackson B. Listeriosis outbreaks associated with soft cheeses, United States, 1998–2014. Emerg Infect Dis 2018;24:1116–8. https://doi.org/10.3201/eid2406.171051 PMID:29774843
FIGURE. Number of persons infected with the outbreak strain of Listeria monocytogenes, by date of specimen collection (n = 13) — United States, October 20, 2020–March 17, 2021
Abbreviations: CT = Connecticut; FDA = Food and Drug Administration; Lm = Listeria monocytogenes; MD = Maryland.
Suggested citation for this article: Palacios A, Otto M, Flaherty E, et al. Multistate Outbreak of Listeria monocytogenes Infections Linked to Queso Fresco — United States, 2021. MMWR Morb Mortal Wkly Rep 2022;71:709–712. DOI: http://dx.doi.org/10.15585/mmwr.mm7121a3.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to firstname.lastname@example.org.